PCM Encore’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Buy
1,536
+27
+2% +$10K 0.1% 181
2026
Q1
$442K Sell
1,509
-29
-2% -$9.53K 0.09% 227
2025
Q4
$539K Buy
+1,538
New +$520K 0.11% 181

Other funds holding ELV

PCM Encore's ELV Position: Q2 2026 in Review

PCM Encore increased its Elevance Health (ELV) stake by 1.8% in Q2 2026, buying an estimated $10K and bringing the position to 1,536 shares worth $594K. The position accounts for 0.1% of the portfolio, ranked #181.

PCM Encore first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PCM Encore held 1,536 shares of Elevance Health worth $594K as of Q2 2026.
  • PCM Encore bought 27 Elevance Health shares in Q2 2026, an estimated $10K.
  • Elevance Health made up 0.1% of PCM Encore's portfolio in Q2 2026, its #181 holding.
  • PCM Encore first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.